ArticleBone marrow transplantation2014

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.

J Labrador et al.PubMed ↗Publisher ↗

No numbers read from the abstract.